Papers
9
Total Citations
1,114
H-Index
8
About
Thomas J. Herzog is a leading figure in gynecologic oncology whose research has fundamentally shaped the modern surgical landscape for women with cancer and benign disease. His work centers on the comparative effectiveness and health economics of minimally invasive surgery, particularly robotic-assisted hysterectomy. Herzog’s landmark 2013 study in JAMA, cited over 575 times, provided crucial population-level evidence on the uptake, complications, and costs of robotic versus laparoscopic hysterectomy for benign conditions, revealing significant cost disparities without clear clinical advantages. He extended this analysis to endometrial and cervical cancers, demonstrating that robotic surgery offered no major safety or efficacy benefits over laparoscopy while substantially increasing healthcare expenditures. Herzog’s critical eye also exposed the aggressive, often unsubstantiated marketing of robotic surgery by hospitals, a topic he explored in a highly cited 2012 study. With over 1,100 total citations across his top papers, his work has become essential reading for surgeons, policymakers, and hospital administrators. By rigorously interrogating the real-world value of new technologies, Herzog has championed evidence-based, cost-conscious care in gynecologic surgery, making him a vital voice in the ongoing debate over surgical innovation and resource allocation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4An Economic Analysis of Robotically Assisted Hysterectomy99 citations · 2014
- 5
- 6
- 7Unintended Consequences: Surgical Complications in Gynecologic Cancer12 citations · 2013
- 8
- 9